Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Quality of Life Research
Published in: Quality of Life Research 12/2018

Open Access 01-12-2018

Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study

Authors: Milea J. M. Timbergen, Lonneke V. van de Poll-Franse, Dirk J. Grünhagen, Winette T. van der Graaf, Stefan Sleijfer, Cornelis Verhoef, Olga Husson

Published in: Quality of Life Research | Issue 12/2018

Login to get access

Abstract

Purpose

Sporadic desmoid-type fibromatosis (DTF) is a rare, chronic, non-metastasising, disease of the soft tissues. It is characterised by local invasive and unpredictable growth behaviour and a high propensity of local recurrence after surgery thereby often having a great impact on health-related quality of life (HRQL). This study aims to review currently used HRQL measures and to asses HRQL issues among DTF patients.

Methods

A mixed methods methodology was used consisting of (1) a systematic literature review, according to the PRISMA guidelines (2009), using search terms related to sporadic DTF and HRQL in commonly used databases (e.g. Embase, Medline Ovid, Web of science, Cochrane Central, Psyc Info, and Google scholar), to provide an overview of measures previously used to evaluate HRQL among DTF patients; (2) focus groups to gain insight into HRQL issues experienced by DTF patients.

Results

The search strategy identified thirteen articles reporting HRQL measures using a wide variety of cancer-specific HRQL tools, functional scores, symptom scales (e.g. NRS), and single-item outcomes (e.g. pain and functional impairment). No DTF-specific HRQL tool was found. Qualitative analysis of three focus groups (6 males, 9 females) showed that participants emphasised the negative impact of DTF and/or its treatment on several HRQL domains. Six themes were identified: (1) diagnosis, (2) treatment, (3) follow-up and recurrence, (4) physical domain, (5) psychological and emotional domain, and (6) social domain.

Conclusion

A DTF-specific HRQL tool and consensus regarding the preferred measurement tool among DTF patients is lacking. Our study indicates that HRQL of DTF patients was negatively affected in several domains. A DTF-specific HRQL measure could improve our understanding of short- and long-term effects and, ideally, can be used in both clinic and for research purposes.
Appendix
Available only for authorised users
Literature
1.
World Health Organization (2016). International statistical classification of diseases and related health problems, 10th revision, volume 3.
2.
van Broekhoven, D. L., et al. (2015). Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: A population-based study. Annals of Surgical Oncology, 22, 2817–2823.CrossRef
3.
De Marchis, M. L., et al. (2017) Desmoid tumors in familial adenomatous polyposis. Anticancer Research, 37, 3357–3336.
4.
Lips, D. J., et al. (2009). The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors). European Journal of Surgical Oncology, 35, 3–10.CrossRef
5.
Reitamo, J. J., et al. (1986). The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. The American Journal of Surgery, 151, 230–237.CrossRef
6.
Mullen, J. T., et al. (2013). β-catenin mutation status and outcomes in sporadic desmoid tumors. The Oncologist, 18, 1043–1049.CrossRef
7.
van Broekhoven, D. L., et al. (2015). Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Annals of Surgical Oncology, 22, 1464–1470.CrossRef
8.
Fiore, M., et al. (2014). Desmoid-type fibromatosis and pregnancy: A multi-institutional analysis of recurrence and obstetric risk. Annals of Surgery, 259, 973–978.CrossRef
9.
Sleijfer, S. (2009). Management of aggressive fibromatosis: Can we unravel the maze of treatment options? European Journal of Cancer, 45, 2928–2929.CrossRef
10.
Colombo, C., et al. (2015) Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients. European Journal of Cancer, 51, 186–192.CrossRef
11.
Salas, S., et al. (2011). Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: A wait-and-see policy according to tumor presentation. Journal of Clinical Oncology, 29, 3553–3558.CrossRef
12.
Al-Jazrawe, M., et al. (2015). Optimal therapy for desmoid tumors: Current options and challenges for the future. Expert Review of Anticancer Therapy, 15, 1443–1458.CrossRef
13.
Penel, N., et al. (2017). Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group. European Journal of Cancer, 83, 125–131.CrossRef
14.
van Broekhoven, D. L., et al. (2016). Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention. BMC Cancer, 16, 686.CrossRef
15.
Landelijke Richtlijn Wekedelen Tumoren, versie 2.0 (2011). Oncoline, richtlijnen oncologische zorg; 2011.
16.
Bonvalot, S., et al. (2013). Spontaneous regression of primary abdominal wall desmoid tumors: More common than previously thought. Annals of Surgical Oncology, 20, 4096–4102.CrossRef
17.
Peng, P. D., et al. (2012). Management and recurrence patterns of desmoids tumors: A multi-institutional analysis of 211 patients. Annals of Surgical Oncology, 19, 4036–4042.CrossRef
18.
Kasper, B., et al. (2017). Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). European Journal of Cancer, 76, 60–67.CrossRef
19.
Bertani, E., et al. (2009). Desmoid tumors of the anterior abdominal wall: Results from a monocentric surgical experience and review of the literature. Annals of Surgical Oncology, 16, 1642–1649.CrossRef
20.
Kasper, B., et al. (2017). An update on the management of sporadic desmoid-type fibromatosis: A European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology, 28, 2399–2408.CrossRef
21.
Marshall, S., et al. (2006). Impact of patient-reported outcome measures on routine practice: A structured review. Journal of Evaluation in Clinical Practice, 12, 559–568.CrossRef
22.
Moher, D., et al. (2010). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery, 8, 336–341.CrossRef
23.
Beaton, D. E., et al. (2001). Measuring the whole or the parts? Validity, reliability, and responsiveness of the disabilities of the arm, shoulder and hand outcome measure in different regions of the upper extremity. Journal of Hand Therapy, 14, 128–146.CrossRef
24.
Dhinsa, B. S., et al. (2014). The outcome of resection of the distal ulna for tumour without soft-tissue or prosthetic reconstruction. The Bone & Joint Journal, 96, 1392–1395.CrossRef
25.
Hudak, P. L., et al. (1996). Development of an upper extremity outcome measure: The DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). American Journal of Industrial Medicine, 29, 602–608.CrossRef
26.
Engelhardt, T. O., et al. (2008). About the self-reported quality of life after amputation of the hand in patients with upper extremity tumors. Handchirurgie Mikrochirurgie Plastische Chirurgie, 40, 23–30.CrossRef
27.
Tang, F., et al. (2015). Large desmoid-type fibromatosis of the shoulder girdle: Operative approach selection and clinic outcome. International Orthopaedics, 39, 363–369.CrossRef
28.
Gibbons, C. L., et al. (1998). Function after subtotal scapulectomy for neoplasm of bone and soft tissue. The Journal of Bone and Joint Surgery, 80, 38–42.CrossRef
29.
Enneking, W. F., et al. (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clinical Orthopaedics and Related Research, 286, 241–246.
30.
Goubier, J. N., et al. (2003). Desmoid tumors and brachial plexus. Chirurgie de la Main, 22, 203–206.CrossRef
31.
Aaronson, N. K., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.CrossRef
32.
Kummar, S., et al. (2017). Clinical activity of the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis). Journal of Clinical Oncology, 35, 1561–1569.CrossRef
33.
Cleeland, C. S., et al. (2000). Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer, 89, 1634–1646.CrossRef
34.
Catton, C. N., et al. (1995). Aggressive fibromatosis: Optimisation of local management with a retrospective failure analysis. Radiotherapy and Oncology, 34, 17–22.CrossRef
35.
Johnstone, P. A., et al. (1994). Sarcomas of the hand and foot: Analysis of local control and functional result with combined modality therapy in extremity preservation. International Journal of Radiation Oncology Biology Physics, 29, 735–745.CrossRef
36.
Hjermstad, M. J., et al. (2011). Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: A systematic literature review. Journal of Pain and Symptom Management, 41, 1073–1093.CrossRef
37.
Ghanouni, P., et al. (2017). Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: A retrospective multicenter study. European Radiology, 27, 732–740.CrossRef
38.
Fiore, M., et al. (2011) Activity of toremifene in sporadic desmoid-type fibromatosis. Journal of Clinical Oncology, 29 10033.CrossRef
39.
Davis, A. M., et al. (1996). Development of a measure of physical function for patients with bone and soft tissue sarcoma. Quality of Life Research, 5, 508–516.CrossRef
40.
Willeumier, J. J., et al. (2017). Cross-cultural adaptation, translation, and validation of the toronto extremity salvage score for extremity bone and soft tissue tumor patients in Netherlands. Sarcoma, 2017, 6197525.CrossRef
41.
Stoeckle, E., et al. (2009). A critical analysis of treatment strategies in desmoid tumours: A review of a series of 106 cases. European Journal of Surgical Oncology, 35, 129–134.CrossRef
42.
Al-Otaibi, M. L., et al. (2008). Low-dose chemotherapy for extra-abdominal desmoid tumor. Saudi Medical Journal, 29, 1730–1734.PubMed
43.
Hoos, A., et al. (2000) Desmoid tumors of the head and neck: A clinical study of a rare entity. Head and Neck, 22, 814–821.CrossRef
44.
Tausch, A. P., & Menold, N. (2016). Methodological aspects of focus groups in health research: Results of qualitative interviews with focus group moderators. Global Qualitative Nursing Research, 3, 2333393616630466.CrossRef
45.
The Desmoid Tumor Research Foundation (2017). DTRF patient registry.
46.
Paty, J., et al. (2017). Prospective development of a patient reported outcomes (PRO) tool in desmoid tumors: A novel clinical trial endpoint. Journal of Clinical Oncology, 35, 11022.CrossRef
47.
Johnson, C., et al. Guidelines for developing questionnaire modules. On Behalf of EORTC Quality of Life Group 2011.
Metadata
Title
Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study
Authors
Milea J. M. Timbergen
Lonneke V. van de Poll-Franse
Dirk J. Grünhagen
Winette T. van der Graaf
Stefan Sleijfer
Cornelis Verhoef
Olga Husson
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 12/2018
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1931-3

Other articles of this Issue 12/2018

Quality of Life Research 12/2018 Go to the issue

OriginalPaper

Quality of life and stability of tooth color change at three months after dental bleaching

OriginalPaper

Impact of further injury on participation in work and activities among those previously injured: results from a New Zealand prospective cohort study

OriginalPaper

Factors associated with quality of life among married women in rural China: a cross-sectional study

OriginalPaper

Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based PROFILES registry

Brief Communication

Association of individual and area-level socioeconomic conditions with quality of life and glycaemic control in 11- to 21-year-old adolescents with early-onset type 1 diabetes: a cross-sectional study

OriginalPaper

Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)